ArticleACS medicinal chemistry letters2023

Development and Utilization of Novel Transglutaminase 2 Inhibitors for Potential Treatment of Autoimmune Disease and Gastrointestinal Disorder.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.